The global burden of disease study 2013: What does it mean for the NTDs?

doi:10.1371/journal.pntd.0005424

. 2017 Aug 3;11(8):e0005424.

doi: 10.1371/journal.pntd.0005424. eCollection 2017 Aug.

The global burden of disease study 2013: What does it mean for the NTDs?

Jennifer R Herricks ^{1

2}, Peter J Hotez ^{1

2

3

4

5}, Valentine Wanga ⁶, Luc E Coffeng ^{6

7}, Juanita A Haagsma ^{6

7}, María-Gloria Basáñez ⁸, Geoffrey Buckle ⁹, Christine M Budke ¹⁰, Hélène Carabin ¹¹, Eric M Fèvre ^{12

13}, Thomas Fürst ^{14

15

16}, Yara A Halasa ¹⁷, Charles H King ¹⁸, Michele E Murdoch ¹⁹, Kapa D Ramaiah ²⁰, Donald S Shepard ¹⁷, Wilma A Stolk ⁶, Eduardo A Undurraga ¹⁷, Jeffrey D Stanaway ⁶, Mohsen Naghavi ⁶, Christopher J L Murray ⁶

Affiliations

¹ Department of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America.
² James A. Baker III Institute for Public Policy, Rice University, Houston, Texas, United States of America.
³ Texas Children's Hospital Center for Vaccine Development, Houston, Texas, United States of America.
⁴ Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University, College Station, Texas, United States of America.
⁵ Department of Biology, Baylor University, Waco, Texas, United States of America.
⁶ Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, United States of America.
⁷ Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
⁸ London Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
⁹ University of California, San Francisco, San Francisco, California, United States of America.
¹⁰ Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, United States of America.
¹¹ Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.
¹² International Livestock Research Institute, Nairobi, Kenya.
¹³ Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
¹⁴ School of Public Health, Imperial College London, London, United Kingdom.
¹⁵ Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.
¹⁶ University of Basel, Basel, Switzerland.
¹⁷ Schneider Institutes for Health Policy, Brandeis University, Waltham, Massachusetts, United States of America.
¹⁸ Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.
¹⁹ Department of Dermatology, Watford General Hospital, Watford, Herts, United Kingdom.
²⁰ Consultant on Lymphatic Filariasis, Tagore Nagar, Pondicherry, India.

PMID: 28771480
PMCID: PMC5542388
DOI: 10.1371/journal.pntd.0005424

The global burden of disease study 2013: What does it mean for the NTDs?

Jennifer R Herricks et al. PLoS Negl Trop Dis. 2017.

. 2017 Aug 3;11(8):e0005424.

doi: 10.1371/journal.pntd.0005424. eCollection 2017 Aug.

Authors

Jennifer R Herricks ^{1

2}, Peter J Hotez ^{1

2

3

4

5}, Valentine Wanga ⁶, Luc E Coffeng ^{6

7}, Juanita A Haagsma ^{6

7}, María-Gloria Basáñez ⁸, Geoffrey Buckle ⁹, Christine M Budke ¹⁰, Hélène Carabin ¹¹, Eric M Fèvre ^{12

13}, Thomas Fürst ^{14

15

16}, Yara A Halasa ¹⁷, Charles H King ¹⁸, Michele E Murdoch ¹⁹, Kapa D Ramaiah ²⁰, Donald S Shepard ¹⁷, Wilma A Stolk ⁶, Eduardo A Undurraga ¹⁷, Jeffrey D Stanaway ⁶, Mohsen Naghavi ⁶, Christopher J L Murray ⁶

Affiliations

¹ Department of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America.
² James A. Baker III Institute for Public Policy, Rice University, Houston, Texas, United States of America.
³ Texas Children's Hospital Center for Vaccine Development, Houston, Texas, United States of America.
⁴ Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University, College Station, Texas, United States of America.
⁵ Department of Biology, Baylor University, Waco, Texas, United States of America.
⁶ Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, United States of America.
⁷ Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
⁸ London Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
⁹ University of California, San Francisco, San Francisco, California, United States of America.
¹⁰ Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, United States of America.
¹¹ Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.
¹² International Livestock Research Institute, Nairobi, Kenya.
¹³ Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
¹⁴ School of Public Health, Imperial College London, London, United Kingdom.
¹⁵ Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.
¹⁶ University of Basel, Basel, Switzerland.
¹⁷ Schneider Institutes for Health Policy, Brandeis University, Waltham, Massachusetts, United States of America.
¹⁸ Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.
¹⁹ Department of Dermatology, Watford General Hospital, Watford, Herts, United Kingdom.
²⁰ Consultant on Lymphatic Filariasis, Tagore Nagar, Pondicherry, India.

PMID: 28771480
PMCID: PMC5542388
DOI: 10.1371/journal.pntd.0005424

No abstract available

PubMed Disclaimer

Conflict of interest statement

PJH is principal investigator and patentholder on various vaccines in development that would provide protection from neglected tropical diseases. DSS has received grant funding from Sanofi Pasteur. The other authors declare no conflicts of interest.

Figures

Fig 1

Fig 1. Global dengue incidence per 100,000 person-years in 2013.

Adapted from Stanaway et al. [40]. NOTE: No estimates are available for Western Sahara as it was not a modeled location in the Global Burden of Disease Study (GBD) 2013.

Fig 2

Fig 2. Global cutaneous/mucocutaneous leishmaniasis prevalence per 100,000 population in 2013.

NOTE: No estimates are available for Western Sahara as it was not a modeled location in the Global Burden of Disease Study (GBD) 2013.

Fig 3

Fig 3. Countries with highest NTD prevalence in 2013.

Countries with the highest prevalence (per 100,000 population) for the diseases indicated and the estimated prevalence in each country. Countries are color coded by Global Burden of Disease Study (GBD) regions. Abbreviations: CAR, Central African Republic; DRC, Democratic Republic of the Congo; STP, São Tomé and Principe. *Also includes mucocutaneous leishmaniasis, **Incidence rather than prevalence.

Fig 4

Fig 4. Countries with highest absolute number of NTD cases in 2013.

Countries with the highest number of absolute cases for the diseases indicated and the estimated numbers in each country. These data are also available from the Institute for Health Metrics and Evaluation (IHME) website. Countries are color coded by Global Burden of Disease Study (GBD) regions. Abbreviations: CAR, Central African Republic; DRC, Democratic Republic of the Congo; STP, São Tomé and Principe. *Also includes mucocutaneous leishmaniasis, **Incident cases rather than prevalent cases, NOTE: As in Table 1, only symptomatic cases are estimated for dengue, trachoma, cystic echinococcosis, cysticercosis, and rabies.

Fig 5

Fig 5. Deaths per 100,000 population by age and sex in 2013.

The data used to generate this figure are also available on the Institute for Health Metrics and Evaluation (IHME) website.

Fig 6

Fig 6. Disability-adjusted life years (DALYs) per 100,000 population by age and gender in 2013.

The estimates used to generate this figure are also available on the Institute for Health Metrics and Evaluation (IHME) website.

Fig 7

Fig 7. Proportional representation of disability-adjusted life years (DALYs) (per 100,000 population) from all NTDs combined in 1990 and 2013 by Global Burden of Disease Study (GBD) super region.

Each bar represents the total disability-adjusted life years (DALYs) per 100,000 population for WHO-prioritized NTDs combined by GBD super region, broken down by percentage of years of life lost (YLLs) (darker shading) and years lived with disability (YLDs) (lighter shading). GBD-estimated numbers for DALY, YLL, and YLD rates for each super region in 1990 and 2013 are shown in the key.

See this image and copyright information in PMC

References

1. Hotez PJ, Alvarado M, Basáñez MG, Bolliger I, Bourne R, Boussinesq M, et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis. 2014;8(7):e2865 doi: 10.1371/journal.pntd.0002865 ; PubMed Central PMCID: PMC4109880. - DOI - PMC - PubMed
1. Global Burden of Disease DALYS HALE Collaborators, Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145–91. doi: 10.1016/S0140-6736(15)61340-X ; PubMed Central PMCID: PMC4673910. - DOI - PMC - PubMed
1. Global Burden of Disease Study Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800. doi: 10.1016/S0140-6736(15)60692-4 ; PubMed Central PMCID: PMC4561509. - DOI - PMC - PubMed
1. Global Burden of Disease Mortality Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–71. doi: 10.1016/S0140-6736(14)61682-2 ; PubMed Central PMCID: PMC4340604. - DOI - PMC - PubMed
1. Beyrer C, Villar JC, Suwanvanichkij V, Singh S, Baral SD, Mills EJ. Neglected diseases, civil conflicts, and the right to health. Lancet. 2007;370(9587):619–27. doi: 10.1016/S0140-6736(07)61301-4 . - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information

[1] Hotez PJ, Alvarado M, Basáñez MG, Bolliger I, Bourne R, Boussinesq M, et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis. 2014;8(7):e2865 doi: 10.1371/journal.pntd.0002865 ; PubMed Central PMCID: PMC4109880. - DOI - PMC - PubMed

[2] Hotez PJ, Alvarado M, Basáñez MG, Bolliger I, Bourne R, Boussinesq M, et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis. 2014;8(7):e2865 doi: 10.1371/journal.pntd.0002865 ; PubMed Central PMCID: PMC4109880. - DOI - PMC - PubMed

[3] Global Burden of Disease DALYS HALE Collaborators, Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145–91. doi: 10.1016/S0140-6736(15)61340-X ; PubMed Central PMCID: PMC4673910. - DOI - PMC - PubMed

[4] Global Burden of Disease DALYS HALE Collaborators, Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145–91. doi: 10.1016/S0140-6736(15)61340-X ; PubMed Central PMCID: PMC4673910. - DOI - PMC - PubMed

[5] Global Burden of Disease Study Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800. doi: 10.1016/S0140-6736(15)60692-4 ; PubMed Central PMCID: PMC4561509. - DOI - PMC - PubMed

[6] Global Burden of Disease Study Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800. doi: 10.1016/S0140-6736(15)60692-4 ; PubMed Central PMCID: PMC4561509. - DOI - PMC - PubMed

[7] Global Burden of Disease Mortality Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–71. doi: 10.1016/S0140-6736(14)61682-2 ; PubMed Central PMCID: PMC4340604. - DOI - PMC - PubMed

[8] Global Burden of Disease Mortality Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–71. doi: 10.1016/S0140-6736(14)61682-2 ; PubMed Central PMCID: PMC4340604. - DOI - PMC - PubMed

[9] Beyrer C, Villar JC, Suwanvanichkij V, Singh S, Baral SD, Mills EJ. Neglected diseases, civil conflicts, and the right to health. Lancet. 2007;370(9587):619–27. doi: 10.1016/S0140-6736(07)61301-4 . - DOI - PubMed

[10] Beyrer C, Villar JC, Suwanvanichkij V, Singh S, Baral SD, Mills EJ. Neglected diseases, civil conflicts, and the right to health. Lancet. 2007;370(9587):619–27. doi: 10.1016/S0140-6736(07)61301-4 . - DOI - PubMed

Account

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The global burden of disease study 2013: What does it mean for the NTDs?

Affiliations

The global burden of disease study 2013: What does it mean for the NTDs?

Authors

Affiliations

Conflict of interest statement

Figures

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical